Tetra Radar · FDA Approvals · Decision date
atacicept: FDA decision date
Vera Therapeutics Inc (VERA) · 7 July 2026
Potential FDA accelerated approval of atacicept in IgAN with a PDUFA date of July 7, 2026.
Source: 8-K of 7 May 2026
The FDA approved it on 7 July 2026.
The FDA approved Trutakna to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk for disease progression.
Vera Therapeutics Inc on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.